Providence Health & Services Selects Compuware to Improve Performance and Availability of Clinical A
Providence Health & Services Washington Region is part of a 27-hospital healthcare system located in Renton, WA.   06:07 Feb 9, 2010

Lithera Successfully Completes Phase I Clinical Trial of LIPO-102
About LIPO-102 LIPO-102 is being developed as a first-in-class injectable drug product designed to produce local, selective fat tissue reduction ( pharmaceutical lipoplasty).   06:07 Feb 9, 2010

Liberty Analytics Co. Initiates Independent Research Coverage on NexMed, Inc.
CALGARY, Alberta, Feb. 9, 2010 ( GLOBE NEWSWIRE)- Liberty Analytics Co., a leading provider of large, small- and micro-cap independent investment research, today initiated coverage on NexMed, Inc..   06:07 Feb 9, 2010

Nabi Biopharmaceuticals Announces Mailing of Definitive Proxy Statement
ROCKVILLE, Md., Feb. 9, 2010 ( GLOBE NEWSWIRE)- Nabi Biopharmaceuticals ( the " Company") announced today that it has commenced mailing its definitive proxy statement to stockholders for approval of the exclusive option and license agreemen   06:07 Feb 9, 2010

Aastrom Announces One-for-Eight Reverse Stock Split
The reverse stock split is intended to increase the per share trading price of Aastrom's common stock to satisfy the $ 1.00 minimum bid price requirement for continued listing on NASDAQ and to attract greater institutional ownership of the   05:38 Feb 9, 2010

Ingen Takes Final Steps Towards Increased Export Sales
ISO Certification is expected to result in a large revenue jump of the company's respiratory product lines. http:// www.bsiamerica. com/ http:// www.emergogroup. com/services- by-region/ usa http:// www. ingen-tech. com/ About Ingen: Ingen   05:26 Feb 9, 2010

Penwest Initiates Second Phase IIa Clinical Trial for A0001
Important factors that could cause results to differ materially include the following: the timing of clinical trials, such as the Phase IIa clinical trial referenced above, and risks related to patient enrollment; risks relating to the comm   05:06 Feb 9, 2010

Chelsea Therapeutics Announces Advancements in Neurogenic Orthostatic Hypotension Registration Progr
About Northera Northera ( droxidopa), the lead investigational agent in Chelsea Therapeutics' broad pipeline, is currently in Phase III clinical trials for the treatment of symptomatic neurogenic orthostatic hypotension ( NOH) in patients w   04:38 Feb 9, 2010

Stock Alert for Medical International Technology Inc. Issued by StockPreacher
To read the entire report visit: http:// www.stockpreacher. com/n/ MDLH See what investors are saying about MDLH at penny stock forum StockPreacher. com is a small-cap research and investment commentary provider.   03:52 Feb 9, 2010

QIAGEN Reports Strong Fourth Quarter and Fiscal 2009 Results
QIAGEN N.V. CONDENSED CONSOLIDATED STATEMENTS OF INCOME ( unaudited) Twelve months ( in thousands, except per share data) ended December 31, 2009 2008 Net sales $ 1,009,825 $ 892,975 Cost of sales 342,752 293,285 Gross profit 667,073 599,69   13:06 Feb 8, 2010

Cooper Announces Release Date for First Quarter 2010
The Cooper Companies, Inc. www.coopercos. com) "> manufactures and markets specialty healthcare products through its CooperVision and CooperSurgical units.   13:06 Feb 8, 2010

Cutera Reports Fourth Quarter 2009 Results
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS ( in thousands) ( unaudited) Three Months Ended December September December 31, 30, 31, 2009 2009 2008 Cash flows from operating activities: Net income ( loss) $ 7 ( $ 13,494) ( $ 235) Adjustm   13:06 Feb 8, 2010

Heartland Spine & Specialty Hospital Names Jesse Saucedo Chief Financial Officer
He was a Senior Financial Analyst of CHRISTUS Health St. Elizabeth Hospital in Beaumont, Texas, and also CFO at CHRISTUS Health Jasper Memorial Hospital in Jasper, Texas.   13:06 Feb 8, 2010

DMS Health Technologies Receives Renewal for The Joint Commission Accreditation for Ambulatory Healt
" Achieving accreditation demonstrates DMS Health Technologies has voluntarily sought an independent evaluation of its compliance with state-of-the-art performance standards", says Michael Kulczycki, executive director, Ambulatory Care Accr   09:52 Feb 8, 2010

...

News Copyright © 2006 Interest!ALERT